19^th European Gastroenterology and Therapeutics Congress

Professor Higinio T. Mappala is a Full-time Medical Specialist IV and Administrator at the Jose Reyes Memorial Medical Center, Manila, Philippines, A Board-certified Internist, Gastroenterologist, Endoscopist, Clinical Nutritionist and Clinical Toxicologist; has served as a University Professor and Dean of 2 Medical Schools; a highly-regarded Researcher, with more than 70 scientific papers, and more than 30 international publications. A former Board Director of the Philippine Societies of Gastroenterology and Digestive Endoscopy; Editorial Board member, American Journal of Biomedical Science and Research; Online Research rater of High quality Research Papers for McMaster, Canada and Online DynaMed Research peer-reviewer; a Young Investigator’s Awardee at the World Congress and Asia-Pacific Congress of Gastroenterology; A nominee as one of the Top 100 Leading Physicians 2018, Cambridge Biographical Institute; Cited as one of “Leading Health Professionals of the World in Gastroenterology and Endoscopy 2010” - British Biographical Institutes, Cambridge, England Nominated as “Ambassador to the World in Gastroenterology and Digestive Endoscopy”-American Institute of Sciences. Presented as Keynote Speaker in more than 700 International and local Conferences / Conventions, and Large-to Small-Group Lectures With 18 Invites as Keynote Speaker in International Conferences, 2018; 51 invites in 2019and 54 invites for 2020.

Gastroenterology, Endoscopy, Clinical Nutrition and Clinical Toxicology

Dr. Larry Good has been a practicing gastroenterologist since 1978. Dr. Good graduated Colgate University Magna Cum Laude in 1969 and received his M.D. with Alpha Omega Alpha status from the Medical University of South Carolina in Charleston, SC in 1973. Dr. Good served a medical residency from 1973-76 and was Chief Medical Resident in 1976. He was fellowship trained in gastroenterology from 1976-78. Dr. Good has served as the Director of Liver Diseases at Nassau County Medical Center and was for many years Chief, Division of Gastroenterology, Department of Medicine at South Nassau Communities Hospital. Dr. Good is an assistant clinical professor of medicine at SUNY Stony Brook. He has given hundreds of lectures in his field and has authored numerous papers and abstracts. Recently, Dr. Good presented the ACG Theater lecture at the American College of Gastroenterology annual meeting in Chicago, Illinois in October, 2014. Dr. Good was Chief Medical Officer at Ritter Pharmaceuticals in Los Angeles, California, where he expanded his research interest in the intestinal microbiome. Dr. Good’s current clinical research activities involve the microbiome, inflammatory bowel disease, irritable bowel syndrome and the application of orally administered gamma globulin to patients with acute and chronic gastro-intestinal disorders. Dr. Good founded Good Pharmaceutical Development Co., LLC, in 2014. He is their CEO and is developing a topical product for treating neuropathic pain. Dr. Good was recently appointed CEO of Compassionate Care Center of New York, a company founded to provide medical marijuana product safely and affordably to residents of New York State adhering to the evolving NYS regulations and producing a pharmaceutical grade treatment option for specific diagnosis designated use. Dr. Good was appointed as an editor of BMC Gastroenterology, a prestigious on line peer-reviewed medical journal. He is a member of the Speakers Bureau for Entera Health, Abbvie and Cubist Pharmaceuticals. Dr. Good currently receives research grants from Entera Health and Medicus Biosciences. Dr. Good is the former C.E.O. of Compassionate Care Center of NY and has had a long interest in research application of the physiology of natural molecules to multiple disease states. Currently, Dr. Good is the C.E.O. of New Century Health Alliance, L.L.C., a Continuing Medical Education Company certified to provide 6.25 AMA PRA credits for education in the area of medical marijuana treatment. In May, 2016, Dr. Good was named to the Steering Committee for Medical Marijuana Research and Education Division, Department of Integrated Medicine at Thomas Jefferson Medical University in Philadelphia. He has just completed a manuscript soon to be published on the treatment of Crohn’s Disease and Ulcerative Colitis with medical marijuana pharmaceuticals.

Gastroenterology, Crohn's Disease, Ulcerative Colitis

Professor Bingrong Liu has done a lot of work as the director of the Department of Gastroenterology, the Second Affiliated Hospital of Harbin University since June 2004. Professor Bingrong Liu and his team has promoted a great development of the Department with an annual income of more than 35 million USD, compared with that of 2.3 million USD before 2004. Now, The department has 240 beds and 3 endoscopy centers with an annual endoscopic check-ups and treatments of about 70 thousand cases and an annual outpatient reception of over 110 thousand cases. It has become a high reputation department both at home and abroad.Professor Bingrong Liu initiated the painless gastroenteroscopic examinations in 2002 in the three northeast provinces. And has been engaged in the work of interventional treatment of liver cancer and achieved a good result.In 2008, professor Bingrong Liu began to carry out earlier in China the work of ESD. And thereon, he and his team began to implement the most advanced techniques of EMD, EFR, tEMD, POEM, and has completed a large number of difficult endoscopic treatments and has saved a lot of severe patients, attracted patients from all over the country and from Russia too.Professor Bingrong Liu is now the President of the Hospital of the GI Diseases of the First Affiliated Hospital of the Zhengzhou University

Endoscopy, EMD,EFR,tEMD,POEM

Dr. Brisebois is an Internal Medicine Specialist (Complex Patient Care) and Palliative Care Specialist. She is the Medicine Site Chief at the Grey Nuns Hospital, Edmonton. She has been practicing for 17 years, in both acute care and community environments. She has a special interest in non-cancer serious illness care. She has published and spoken internationally on these topics. She is deeply involved with the Strategic Health Networks of the Alberta Health Services programs that focus on improving care for patients and families in these areas. Dr. Brisebois’ areas of expertise include Advance Care Planning (Living Wills, Personal Directives) and integration with Goals of Care designations, living fully with chronic illness by minimizing symptoms, navigation of the health system, and dispersed education in these areas. She has won numerous teaching awards, and has received multiple grants to further her work in these areas.

Advance Care Planning (Living Wills, Personal Directives) and integration with Goals of Care designations, living fully with chronic illness by minimizing symptoms, navigation of the health system, and dispersed education

Dr. Willingham is a member of Winship Cancer Institute of Emory University and serves as Director of Endoscopy in Emory University's Division of Digestive Disease. He began practicing with Emory Healthcare in 2009 and is board certified in gastroenterology and internal medicine.He is a member of the American College of Physicians, the American Gastrointestinal Association, the American College of Gastroenterology, and the American Society of Gastrointestinal Endoscopy.

endoscopy, enteroscopy small bowel, gallbladder disease, gastroesophageal reflux, gastrointestinal bleed, gastrointestinal motility, gastrointestinal tumors, pancreatic disease, pancreatitis, radiofrequency ablation,small bowel endoscop

MBBS, King Saud University School of Medicine, Riyadh, Saudi Arabia, 1993 Internship, Department of Medicine, Pediatrics, Surgery and Obstetrics & Gynecology, Security Forces Hospital, Riyadh, Saudi Arabia, 1994 Residency, Internal Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia, 1999 Fellowship, Gastroenterology and Hepatology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia, 2001 Fellowship, Liver Transplantation Hepatology, University of Virginia Health System, Charlottesville, VA, 2003

Exploring and conducting new HCV therapies in the post-liver transplant population,Liver transplant outcomes